- Home
- NXT vs QGEN Comparison
NXT vs QGEN Comparison
Compare NXT & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXT
- QGEN
- Stock Information
- Founded
- NXT 2013
- QGEN 1986
- Country
- NXT United States
- QGEN Netherlands
- Employees
- NXT N/A
- QGEN N/A
- Industry
- NXT Semiconductors
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NXT Technology
- QGEN Health Care
- Exchange
- NXT Nasdaq
- QGEN Nasdaq
- Market Cap
- NXT 8.8B
- QGEN 10.3B
- IPO Year
- NXT 2023
- QGEN 1996
- Fundamental
- Price
- NXT $68.77
- QGEN $49.74
- Analyst Decision
- NXT Buy
- QGEN Buy
- Analyst Count
- NXT 19
- QGEN 8
- Target Price
- NXT $63.74
- QGEN $51.01
- AVG Volume (30 Days)
- NXT 3.0M
- QGEN 1.3M
- Earning Date
- NXT 07-29-2025
- QGEN 08-05-2025
- Dividend Yield
- NXT N/A
- QGEN 3.07%
- EPS Growth
- NXT N/A
- QGEN 405.07
- EPS
- NXT 3.67
- QGEN 1.69
- Revenue
- NXT $3,103,529,000.00
- QGEN $2,040,067,000.00
- Revenue This Year
- NXT $13.65
- QGEN $6.41
- Revenue Next Year
- NXT $10.67
- QGEN $5.70
- P/E Ratio
- NXT $18.74
- QGEN $29.38
- Revenue Growth
- NXT 13.26
- QGEN 5.15
- 52 Week Low
- NXT $30.93
- QGEN $37.63
- 52 Week High
- NXT $70.14
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- NXT 64.78
- QGEN 55.69
- Support Level
- NXT $63.87
- QGEN $48.62
- Resistance Level
- NXT $70.14
- QGEN $49.50
- Average True Range (ATR)
- NXT 3.04
- QGEN 0.72
- MACD
- NXT 1.32
- QGEN -0.03
- Stochastic Oscillator
- NXT 92.18
- QGEN 82.19
About NXT Nextracker Inc.
Nextracker (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextracker has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).